Lineage-specific clonality analysis of chronic myeloproliferative disorders and myelodysplastic syndrome by human androgen receptor assay

Pathology and Oncology Research

Volumn 13, Issue 2, 2007, Pages 114-122

  Jáksó, Pál ^a   Kereskai, László ^a   Molnár, Lenke ^a   Pajor, László ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Chronic myeloproliferative disease; HUMARA; Myelodysplasia

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CLINICAL ARTICLE; CLONAL VARIATION; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN EXPERIMENT; LYMPHOID CELL; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NORMAL HUMAN; POLYMERASE CHAIN REACTION;

EID: 34547638253     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02893486     Document Type: Article

References (18)

1. Allen RC, Zoghbi HY, Moseley AB: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229-1239, 1992
2. Anderson JE, Gilliland DG, List AF: Myelodysplastic syndrome. Educational Materials by the American Society of Hematology, 1998
3. Baxter EJ, Scott LM, Campbell PJ: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054-1061, 2005
4. Busque L, Gilliland DG: X-inactivation analysis in the 1990s: promise and potential problems. Leukemia 12:128-135, 1998
5. Culligan DJ, Cachia P, Wittaker J: Clonal lymphocytes are detectable in only some cases of MDS. Br J Haematol 81:346-352, 1992
6. Heaney ML, Golde DW: Myelodysplasia. N Engl J Med 340:1649-1660, 1999
7. Hellström-Lindberg E, Willmann C, Barrett AJ: Achievements in understanding and treatment of myelodysplastic syndromes. Educational Materials by the American Society of Hematology, 2000.
8. Jaffe ES, Harris NL, Stein H, Vardinian JW eds. World Health Organization Classification of Tumours, Pathology & Genetics, Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2001
9. James C, Ugo V, Le Couedic JP: A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434:1144-1148, 2005
10. Knuutila S, Teerenhovi L, Larramendy ML: Cell lineage involvement of recurrent chromosomal abnormalities in hematological neoplasms. Genes, Chromosomes Cancer 10:95-102, 1994
11. Kralovics R, Passamonti F, Buser AS: A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352:1779-1790, 2005
12. Levine RL, Wadleigh M, Cools J: Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocytemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7:387-397, 2005
13. Nilsson L, Åstrand-Grundström I: Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood 156:2012-2021, 2000
14. Pajor L, Matolcsy A, Vass JA, Méhes G, Marton É, Szabó F: Phenotypic and genotypic analyses of blastic cell population suggest that pure B-lymphoblastic leukemia may arise from myelodysplastic syndrome. Leuk Res 22:13-17, 1998
15. Pearson TC, Messinezy M, Westwood N: A Polycythemia Vera Update: diagnosis, pathobiology, and treatment. Educational Materials by the American Society of Hematology, 2000.
16. Raskind WH, Steinmann L, Najfeld V: Clonal development of myeloproliferative disorders: clues to hematopoietic differentiation and multistep pathogenesis of cancer. Leukemia 12: 108-116, 1998
17. Tonon L, Bergamaschi G, Dellavecchia C, Rosti V, Lucotti C, Malabarba: Unbalanced X-chromosome inactivation in haematopoietic cells from normal women. Br J Haematol 102:996-1003, 1998
18. Zhao R, Xing S, Li Z: Identification of an acquired JAK2 mutation in Polycythemia vera. J Biol Chem 280:22788-22792, 2005